Clinical trial Recruiting at 1 site Interventional Ages 18 to 35

Ischemic Release vs. Sustained Pressure Direct Myofascial Release for Upper Trapezius Trigger Points

Official title: Comparison of Ischemic Release and Sustained Pressure Direct Myofascial Release in Upper Trapezius Trigger Point

Run by Foundation University Islamabad · NCT07838584 · Data updated 2026-11-12

In people with upper trapezius trigger points, this study tests whether ischemic release or sustained pressure direct myofascial release helps reduce pain and improve neck movement.

Quick facts

Study typeInterventional
Ages18 Years to 35 Years
SexAll
Enrollment42 (estimated)
SponsorFoundation University Islamabad
Academic / other
Locations1 site (Islamabad, Punjab Province)
StatusRecruiting
StartedSeptember 9, 2026
Main results expectedDecember 18, 2026
Study endsJanuary 18, 2027
Registry record updatedOctober 5, 2026
Trial IDNCT07838584 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–35 with unilateral upper trapezius trigger points and subacute neck pain (4–12 weeks) who have a pain rating of 3–8 and demonstrable range-of-motion changes.

Probably not a fit

Individuals with serious pathology, radiculopathy, recent whiplash, or prior cervical/shoulder surgery may not benefit from these therapies.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial compares two manual therapy techniques for upper trapezius trigger points: ischemic release and sustained pressure direct myofascial release. Thirty-two participants with subacute neck pain and active trigger points are randomly assigned to one of the two interventions for a two-week period. Outcomes include pain pressure threshold, cervical range of motion, and scapular upward rotation, measured at baseline and after the intervention. Participants are adults aged 18 to 35 recruited from Foundation University College of Physical Therapy, Islamabad. The study uses purposive sampling for eligibility and follows standard safety and consent procedures.

Why it matters

Potential benefit: If successful, the therapy that yields greater pain relief and range of motion could become a preferred approach for managing upper trapezius trigger points.

How similar studies have gone: Previous studies in manual therapy for myofascial trigger points have shown mixed but promising results for similar techniques, supporting further investigation like this trial.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* AGE; 18-35 years
* Male \& Female
* Unilateral Trapezius muscle involvement
* Presence of at least one active trigger point in upper trapezius muscle.
* Numeric Pain Rating Scale (NPRS) score of 3-8 points
* Subacute Neck pain for 4-12 weeks
* Point tenderness on palpable taut band
* Reproducible provocation according to referred pain pattern mapping
* Cervical range of motion change in SB ≥ 2° and ROT ≥ 2° than normal SB=45° AND ROT=70°
* Willing to participate and provide informed consent

Exclusion Criteria:

* Serious pathology (e.g. neoplasm, fracture)
* Radiculopathy
* History of whiplash injury within past 6 months
* Neurological deficit
* Taking steroids or on concurrent physiotherapy treatment
* Prior surgery to cervical spine \& shoulder

Where it's running

  • Foundation University College of Physical Therapy
    Islamabad, Punjab Province, Pakistan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.